SEC 13F Intelligence

M28 Capital Management LP / ARWR

M28 Capital Management LP’s Arrowhead Pharmaceuticals In Position

Does M28 Capital Management LP own Arrowhead Pharmaceuticals In (ARWR)? Yes — 36.9K shares worth $2M (+4.29% of its 13F portfolio) as of Q1 2026, down from 67.4K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
36.9K
% of Portfolio
+4.29%
Quarters Held
14
currently held

Position History ARWR

Reported value by quarter
Q4 ’22: $6MQ4 ’22Q1 ’23: $2MQ2 ’23: $2MQ2 ’23Q3 ’23: $2MQ4 ’23: $2MQ4 ’23Q1 ’24: $2MQ2 ’24: $2MQ2 ’24Q3 ’24: $1MQ4 ’24: $1MQ4 ’24Q1 ’25: $858,676Q2 ’25: $1MQ2 ’25Q3 ’25: $2MQ4 ’25: $4MQ4 ’25Q1 ’26: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202636.9K$2M+4.29%
Q4 202567.4K$4M+3.25%
Q3 202567.4K$2M+3.42%
Q2 202567.4K$1M+1.82%
Q1 202567.4K$858,676+1.18%
Q4 202467.4K$1M+1.24%
Q3 202467.4K$1M+1.43%
Q2 202467.4K$2M+2.27%
Q1 202467.4K$2M+1.42%
Q4 202367.4K$2M+1.71%
Q3 202367.4K$2M+2.08%
Q2 202367.4K$2M+3.18%
Q1 202367.4K$2M+1.94%
Q4 2022143.9K$6M+5.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See M28 Capital Management LP’s full portfolio or all institutional holders of ARWR.